Materials and Methods
The isolation and idiotypic characterization of the IgMK mRFs Wa and McD of the Wa group, Lay of the Po group, and Bla of the Bla group have been described in detail previously (1, 2) . Isolation of the IgMK monoclonal anti-low-density lipoprotein (Son) and analysis of light chain amino acid sequences have also been reported previously (6) . Sera of Job and Gag, IgMK monoclonal cold agglutinins, were provided by Dr. R. Williams (Univ. of New Mexico Hospital, Albuquerque, NM). Partial analyses of the amino acid sequences of the light chains of these two proteins have been performed previously, and both characterized as VKIII (11) . The monoclonal cold agglutinins were isolated from serum by high-pressure liquid chromatography using 5000-PW column 7.5 mm x 30 cm (Altex Spherogel-TSK ; Beckman Instruments, Inc ., Fullerton, CA). Immunoblots of denatured light chains isolated by SDS-PAGE were tested by probing Western blots of the gels as reported (8) . Anti-PSL2 and anti-PSL3 (4) were provided by Drs . P. P. Chen and D. A. Carson (Scripps Clinic, La Jolla, CA). Goat anti-human K chain serum was obtained from Kallestad Laboratories (Austin, TX) . Enzymatic digestion, purification of peptides, and analysis of amino acid sequences were performed as described (12).
Results and Discussion
The amino acid sequence of the L-CDR2 of the Bla protein shown in Fig . 1 was identical to that reported for the Wa mRFs. The reactivity of anti-PSL2, anti-PSL3, and anti-K with denatured light chain of the various monoclonal autoantibodies is shown in Fig . 2 . Anti-PSL2 reacted with all light chains except those from Lay, the Po mRF . Anti-PSL3 reacted with light chains of the Wa mRFs, Wa and McD, and Son, the anti-low-density lipoprotein, but not with the light chains of Bla or the cold agglutinins .
The demonstration in this study that the L-CDR2 of Bla mRF is identical to that of the Wa mRFs and that the PSL2-CRI, as determined by anti-PSL2, is present on Bla, a mRF that reacts with DNA nucleoprotein, Son, a monoclonal anti-low-density lipoprotein, and two monoclonal cold agglutinins unequivocally rules out that the PSL2-CRI is associated only with mRFs of the Wa group . On the contrary, these findings suggest that the PSL2-CRI may be a common determinant on most IgMK monoclonal autoantibodies and raise the possibility that the PSL2-CRI is an idiotype involved in a more general regulation of autoantibodies . The high incidence of PSL2-CRI among rheumatoid factors in essential mixed cryoglobulinemia, a disorder in which the rheumatoid factors are usually monoclonal, also supports the hypothesis that PSL2-CRI is associated with monoclonal IgMK autoantibodies (4) .
A major alternative possibility to that of selective association of PSL2-CRI with monoclonal autoantibodies is that the presence of PSL2-CRI among monoclonal autoantibodies reflects the occurrence of the PSL2-CRI in the IgMK pool in pathologic sera. This must be considered for several reasons . A high incidence of PSL2-CRI occurs among VKIIIb light chains (4, 6); VKIIIb light chains make up a substantial portion of K light chains of polyclonal IgM in normal serum, whereas only trace amounts are present among light chains of IgG and IgA (13) . Uncertainty exists about the percentage of VKIIIb light chains present among IgMrc proteins (13, 14) and about the effect of polyclonal increase of IgM on VKIIIb concentrations (15) . Therefore, the high incidence of PSL2-CRI among monoclonal autoantibodies may reflect the relatively high levels of IgMKIIIb that may be present in pathologic sera . Whether VICIIIb and the PSL2-CRI are selectively present in autoantibodies could possibly be determined more definitively from studies of polyclonal autoimmune disease states . Thus far, studies on polyclonal rheumatoid factors are conflicting. Qualitative studies have shown a high incidence of PSL2-CRI, whereas quantitative studies for VKII1b indicate that only small amounts are present (16, 17) . From the evidence presented here and previous studies, which demonstrated that the Wa and Bla XIds are conformational antigens requiring both heavy and light chains, it is clear that the determinant detected by anti-PSL2 is primary structure antigen not directly related to the Wa or Bla XId determinants . It remains to be determined whether PSL2-CRI is indeed an XId that is selectively present on autoantibodies or an allotypic marker for a VKIII germline gene . The latter has not been excluded because somatic mutation of the L-CDR2 could explain the presence of VICIII light chains that do not react with anti-PSL2.
Summary
The amino acid sequence of the L-CDR2 (complementarity-determining region) of Bla mRF (monoclonal rheumatoid factor) is identical to that of the Wa mRFs . The PSL2-CRI (crossreactive idiotype), as determined by anti-PSL2, which has been shown to be present on all Wa mRFs, is also present on the Bla mRF and other monoclonal autoantibodies . PSL2-CRI is, therefore, not unique to Wa mRFs and may be present on most IgMK monoclonal autoantibodies .
Whether PSL2-CRI is a crossidiotype (XId) that is selectively present on autoantibodies or represents an allotypic marker for a VKIII gene is undetermined .
